nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstracts Presented at the 12th Panhellenic Pharmaceutical Congress
|
|
|
2005 |
|
1-2 |
p. 141-144 |
artikel |
2 |
An overview about Biopharmaceutics in Europe
|
Aiache, Jean-Marc |
|
2005 |
|
1-2 |
p. 19-27 |
artikel |
3 |
Bioequivalence of nifedipine softgel and capsule in healthy Chinese volunteers by liquid chromatography–mass spectrometry
|
Zhang, Jing |
|
2010 |
|
1-2 |
p. 67-73 |
artikel |
4 |
Biopharmaceutical characterization of sustained release matrix tablets based on novel carbomer polymers: formulation and in vivo investigation
|
Parojčić, Jelena |
|
2005 |
|
1-2 |
p. 99-104 |
artikel |
5 |
Comparison of the stability of some major cytochrome P450 and conjugation reactions in rat, dog and human hepatocyte monolayers
|
Ubeaud, Genevieve |
|
|
|
1-2 |
p. 37-45 |
artikel |
6 |
[2-14C]Thymidine incorporation activity of stem cells in either tumor or cradle tissues in a normal or transplanted animals
|
Shigematsu, Akiyo |
|
2005 |
|
1-2 |
p. 29-39 |
artikel |
7 |
Detection of nimesulide metabolites in rat plasma and hepatic subcellular fractions by HPLC-UV/DAD and LC-MS/MS studies
|
Küçükgüzel, Ş. Güniz |
|
2005 |
|
1-2 |
p. 127-134 |
artikel |
8 |
Developmental pharmacology and toxicology: Biotransformation of drugs and other xenobiotics during postnatal development
|
Klinger, Wolfgang |
|
2005 |
|
1-2 |
p. 3-17 |
artikel |
9 |
Development and validation of an HPLC method for simultaneous determination of trimethoprim and sulfamethoxazole in human plasma
|
Sayar, Esin |
|
2010 |
|
1-2 |
p. 41-46 |
artikel |
10 |
Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharacokinetic study in dogs
|
Xie, Hai-Tang |
|
2005 |
|
1-2 |
p. 63-67 |
artikel |
11 |
Different effect of erythromycin on absorption kinetics of nimodipine in male and female rats
|
Liu, X. D. |
|
2005 |
|
1-2 |
p. 69-73 |
artikel |
12 |
Disposition of amiodarone in rats after single and multiple intraperitoneal doses
|
Najjar, Tawfeeg A. O. |
|
|
|
1-2 |
p. 65-69 |
artikel |
13 |
Editorial
|
Benakis, A. |
|
2005 |
|
1-2 |
p. 1-2 |
artikel |
14 |
Effects of acylcarnitines on efflux transporting system in Caco-2 cell monolayers
|
Tomita, Mikio |
|
2010 |
|
1-2 |
p. 1-7 |
artikel |
15 |
Establishing individual metabolite patterns for patients on valproate therapy
|
Kreher, U. |
|
|
|
1-2 |
p. 99-107 |
artikel |
16 |
Events
|
|
|
2005 |
|
1-2 |
p. 137-140 |
artikel |
17 |
Impact of hyperlipidaemia on the orbital bone cefotaxime levels in rats
|
Panitsa, G. |
|
2010 |
|
1-2 |
p. 23-27 |
artikel |
18 |
Induction and inactivation of a cytochrome P450 confering herbicide resistance in wheat seedlings
|
Forthoffer, N. |
|
|
|
1-2 |
p. 9-16 |
artikel |
19 |
Influence of bile acid derivates on tramadol analgesic effect in mice
|
Vasovic, V. |
|
2010 |
|
1-2 |
p. 75-78 |
artikel |
20 |
Influence of different calcic antagonists on the Caco-2 cell monolayer integrity or “TEER, a measurement of toxicity ?”
|
Mathieu, F. |
|
2005 |
|
1-2 |
p. 85-90 |
artikel |
21 |
Influence of hepatic regeneration after partial hepatectomy on theophylline pharmacokinetics in rats
|
Maza, A. M. |
|
|
|
1-2 |
p. 53-58 |
artikel |
22 |
Investigation of distribution and elimination of terbutaline sulfate in the perfused rat liver preparation
|
Sahin, Selma |
|
2010 |
|
1-2 |
p. 9-14 |
artikel |
23 |
Investigation of racial variations in the metabolism of tramadol
|
Ogunleye, D. S. |
|
|
|
1-2 |
p. 95-98 |
artikel |
24 |
In vitro andin vivo metabolism of ethyl 4-[(2-hydroxy-1-naphthyl)azo]benzoate
|
Bekce, Banu |
|
2005 |
|
1-2 |
p. 91-97 |
artikel |
25 |
In vivo target recognition with high-resolution imaging: significance for drug development
|
Stumpf, Walter E. |
|
2010 |
|
1-2 |
p. 15-22 |
artikel |
26 |
Letter to the Editor
|
|
|
2005 |
|
1-2 |
p. 47 |
artikel |
27 |
Metabolism of the α-1A-adrenergic receptor antagonist, pyridine-phenylpiperazine analog (RWJ-69597), in rat, dog and human hepatic S9 factions -API-MS/MS identification of metabolites
|
Wu, W. N. |
|
2005 |
|
1-2 |
p. 105-111 |
artikel |
28 |
Metabolism of the new α-1A-adrenergic receptor antagonist, phthalimide-phenylpiperazine analog (RWJ-69442), in rat, dog and human hepatic S9 fractions, and in rats
|
Wu, W. N. |
|
2005 |
|
1-2 |
p. 113-120 |
artikel |
29 |
New Books
|
|
|
2005 |
|
1-2 |
p. 135-136 |
artikel |
30 |
Pharmacokinetic and pharmacodynamic of irbesartan in renal hypertensive dogs under non-steady-state and steady-state conditions
|
Huang, Xiao-Hui |
|
2005 |
|
1-2 |
p. 121-126 |
artikel |
31 |
Pharmacokinetics of vertilmicin, a novel aminoglycoside antibiotic, in rats and dogs
|
Zhou, Mao-Jin |
|
2010 |
|
1-2 |
p. 47-53 |
artikel |
32 |
Speciation of arsenic in urine following intravenous administration of arsthinol in mice
|
Ajana, Imane |
|
2010 |
|
1-2 |
p. 59-65 |
artikel |
33 |
Statistical aspects of bioequivalence testing between two medicinal products
|
Zintzaras, E. |
|
2005 |
|
1-2 |
p. 41-46 |
artikel |
34 |
Survey: calculation of the characteristics of oral diffusion-controlled release dosage forms related to the drug
|
Rosca, I. D. |
|
2010 |
|
1-2 |
p. 29-39 |
artikel |
35 |
The influence of Nifadin®, Niprisan® and Niprd/92/001/1-1 (AM-1) on the pharmacokinetics of metronidazole in rats
|
Bakare-Odunola, M. T. |
|
2010 |
|
1-2 |
p. 55-58 |
artikel |
36 |
The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens
|
Caldwell, Gary W. |
|
2005 |
|
1-2 |
p. 75-83 |
artikel |
37 |
Transport of thalidomide by the human intestinal Caco-2 monolayers
|
Zhou, Shufeng |
|
2005 |
|
1-2 |
p. 49-61 |
artikel |